Literature DB >> 23656988

Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study.

Tuomas Rauramaa1, Maria Pikkarainen, Elisabet Englund, Paul G Ince, Kurt Jellinger, Anders Paetau, Irina Alafuzoff.   

Abstract

There is no consensus on the pathologic conditions or severity implied by the term "hippocampal sclerosis" (HS). In this study, a panel of experienced neuropathologists evaluated inter-rater agreement for pathologic diagnoses in the hippocampus and proposes consensus recommendations on the use of the term "HS." In a group of 251 cases of HS selected from a large autopsy cohort (1,388; 18%), a coordinating group identified 5 patterns of degenerative or vascular pathology. Four independent neuropathologists assessed a single set of hematoxylin and eosin-stained sections following descriptive definitions to classify the appearances and assign the diagnosis of HS, if appropriate. Diagnostic agreement (range, 36%-70%) was highest for vascular lesions. Subsequent joint review of all cases highlighted the need to identify neurodegenerative lesions using immunohistochemistry. Initial agreement in assigning the diagnosis of HS varied from 0% to 86%. After a joint review, the group recommended that the term "HS" should be applied to all cases with complete/near-complete neuronal loss and gliosis in the subfields of the cornu Ammonis but not to hippocampal microinfarction. Therefore, the etiology of HS must be defined in association with a neurodegenerative process or as "lacking neurodegenerative markers," a pathologic condition presumed to arise from hypoxic/ischemic mechanisms.

Entities:  

Mesh:

Year:  2013        PMID: 23656988     DOI: 10.1097/NEN.0b013e318292492a

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  31 in total

1.  TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease.

Authors:  Marina Buciuc; Jennifer L Whitwell; Bradley F Boeve; Tanis J Ferman; Jonathan Graff-Radford; Rodolfo Savica; Kejal Kantarci; Julie A Fields; David S Knopman; Ronald C Petersen; Joseph E Parisi; Melissa E Murray; Dennis W Dickson; Keith A Josephs
Journal:  J Neurol       Date:  2020-01-31       Impact factor: 4.849

2.  The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses.

Authors:  Lilah M Besser; Walter A Kukull; Merilee A Teylan; Eileen H Bigio; Nigel J Cairns; Julia K Kofler; Thomas J Montine; Julie A Schneider; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-08-01       Impact factor: 3.685

3.  FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.

Authors:  Hugo Botha; William G Mantyh; Melissa E Murray; David S Knopman; Scott A Przybelski; Heather J Wiste; Jonathan Graff-Radford; Keith A Josephs; Christopher G Schwarz; Walter K Kremers; Bradley F Boeve; Ronald C Petersen; Mary M Machulda; Joseph E Parisi; Dennis W Dickson; Val Lowe; Clifford R Jack; David T Jones
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

4.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

5.  Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.

Authors:  Marina Buciuc; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Bradley F Boeve; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2020-04-15       Impact factor: 4.673

6.  Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease.

Authors:  Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider
Journal:  Ann Neurol       Date:  2015-04-22       Impact factor: 10.422

7.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

Review 8.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

9.  Differential clinicopathologic and genetic features of late-onset amnestic dementias.

Authors:  Melissa E Murray; Ashley Cannon; Neill R Graff-Radford; Amanda M Liesinger; Nicola J Rutherford; Owen A Ross; Ranjan Duara; Minerva M Carrasquillo; Rosa Rademakers; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-06-05       Impact factor: 17.088

10.  Higher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample.

Authors:  Camila Nascimento; Claudia K Suemoto; Roberta D Rodriguez; Ana Tereza Di Lorenzo Alho; Renata P Leite; Jose Marcelo Farfel; Carlos Augusto Gonçalves Pasqualucci; Wilson Jacob-Filho; Lea T Grinberg
Journal:  Brain Pathol       Date:  2015-09-17       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.